首页> 中文期刊> 《西部中医药》 >丹红注射液联合硝酸酯类药物治疗冠心病心绞痛

丹红注射液联合硝酸酯类药物治疗冠心病心绞痛

         

摘要

Objective:To observe clinical effects of DanHong injection and nitrates in treating angina pectoris of coronary heart disease. Method:All 68 patients were randomized into the treatment group and the control group. Both groups received routine treatment, the observation group intravenous dripping of DanHong injection, 40mL, and 5%blood glucose, 200mL, once per day. Ten days were one course of treatment, clinical effects were observed after one course of treatment. Result: Among 34 cases of the treatment group, there were 16 cases markedly effective, 16 cases effective and two cases ineffective, total effective rate 94.12%. There were 12 cases markedly effective in the control group, 15 cases effective, seven cases ineffective and total effective rate 78.13%. The difference was significant between both groups in clinical effects (P<0.05). There was no complication and adverse reaction in the treatment group. There were two patients complicated with hypotension (5.88%), three cases with headache, flushing and other discomforts (8.82%) and five cases suffering from adverse reaction (14.71%). The difference was significant in the incidence of adverse reaction (P<0.05). Conclusion:DanHong injection and nitrates are effective in treating angina pectoris of coronary heart disease.%目的:观察丹红注射液、硝酸酯类药联合治疗冠心病心绞痛的临床疗效。方法:将68例冠心病心绞痛患者随机分组为治疗组、对照组各34例。2组入院后均予常规治疗,观察组在此基础上给予丹红注射液40 mL+5%葡萄糖200 mL,静脉滴注,1次/d。2组均以10天为1个疗程,1个疗程后观察疗效。结果:治疗组显效16例,有效16例,无效2例,总有效率94.12%;对照组显效12例,有效15例,无效7例,总有效率78.13%;2组临床疗效比较差异显著(P<0.05),治疗组并发症0例,药物不良反应0例,对照组并发低血压2例(占5.88%),头痛、面红等不适者3例(8.82%),药物不良反应15例(14.71%)。2组不良反应发生率比较,差异显著(P<0.05)。结论:丹红注射液联合硝酸酯类药物治疗冠心病心绞痛疗效显著。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号